Buscar
Mostrando ítems 51-60 de 372
Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes
(Elsevier Science Bv, 2017)
Antimicrobial resistance is a major and emerging threat worldwide. New antimicrobials have been unable to meet the resistance challenge, and treatment options are limited for a growing number of resistant pathogens. More ...
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
(Expert Reviews, 2010-01-01)
Pseudomonas aeruginosa and Acinetobacter baumannii are major nosocomial pathogens worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to virtually any antimicrobial agent. An increasing ...
Detection of OXA-231, a new variant of bla(OXA-143,) in Acinetobacter baumannii from Brazil: a case report
(Oxford Univ Press, 2012-10-01)
Epidemiologia e investigação de mecanismos de resistência aos carbapenêmicos e polimixinas em bacilos gram-negativos multirresistentes
(Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da Saúde, 2018-09-28)
Bacterial resistance is a global public health problem and leads to relapsing nosocomial infections, high morbidity and mortality rates and high financial impact. Carbapenems and polymyxins are extensively antimicrobials ...
Avaliação do perfil de sensibilidade de Klebsiella pneumoniae resistente aos carbapenêmicos e à polimixina B frente a polimixina B modificada pela complexação ao íon metálico cobre
(Universidade Estadual Paulista (Unesp), 2019-07-29)
Devido ao crescente isolamento de espécimes de Klebsiella pneumoniae resistentes a praticamente todas as classes de drogas antimicrobianas, a busca por novas drogas que sejam alternativa terapêutica para o tratamento das ...
Avaliação dos desfechos clínicos com uso da terapia antimicrobiana: Polimixina B
(Universidade Federal de Santa MariaBRMedicinaUFSMPrograma de Pós-Graduação em Ciências da Saúde, 2014-11-08)
This study aims at evaluating the clinical outcomes with the use of Polymyxin B, antibiotic that is being increasingly used across the current needs of antimicrobial therapy. Was developed in the 40s for the treatment of ...